04 May 2010 ~ Comments Off on Cancer prevention in underserved African American communities: barriers and effective strategies–a review of the literature

Cancer prevention in underserved African American communities: barriers and effective strategies–a review of the literature

African Americans suffer significantly more cancer morbidity and mortality than the white population. In order to decrease this differential, it is critical to understand the particular barriers to health and health care that underserved African Americans face. It is also important to identify the critical components of effective cancer prevention programs for this population. The […]

Continue Reading

04 May 2010 ~ Comments Off on Ensuring consistent quality care to address disparities in cancer screening

Ensuring consistent quality care to address disparities in cancer screening

Continue Reading

04 May 2010 ~ Comments Off on Nursing contributions to the elimination of health disparities among African-Americans: review and critique of a decade of research

Nursing contributions to the elimination of health disparities among African-Americans: review and critique of a decade of research

The excessive burden of disease experienced by African-Americans has long been described by authorities in the public, private, and professional sector as a national health concern. Several reports have been published in the peer-reviewed literature that describe the outcomes of nurse-directed studies aimed at addressing the factors associated with the disparities experienced by African-Americans and […]

Continue Reading

04 May 2010 ~ Comments Off on Cancer in U.S. ethnic and racial minority populations

Cancer in U.S. ethnic and racial minority populations

Discoveries, breakthroughs, and advances made in the area of cancer prevention and cancer control over the last 2 decades have led to declines in the rates of cancer incidence and mortality and increases in life expectancy and survival for many cancer patients. However, although the trends relative to cancer incidence, mortality, and 5-year survival for […]

Continue Reading

04 May 2010 ~ Comments Off on Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations

Model for incorporating social context in health behavior interventions: applications for cancer prevention for working-class, multiethnic populations

BACKGROUND: This article proposes a conceptual framework for addressing social contextual factors in cancer prevention interventions, and describes work that operationalizes this model in interventions for working class, multiethnic populations. METHODS: The Harvard Cancer Prevention Program Project Includes Three Studies: (1) an intervention study in 25 small businesses; (2) an intervention study in 10 health […]

Continue Reading

04 May 2010 ~ Comments Off on Strategies for reaching Asian Americans with health information

Strategies for reaching Asian Americans with health information

INTRODUCTION: Cultural, linguistic, and economic barriers place many Asian Americans in jeopardy of missing opportunities for disease prevention, early diagnosis, prompt treatment, and participation in clinical trials. One way to learn how to address these barriers is through the development of a demonstration health education and prevention program focused on an indicator disease such as […]

Continue Reading

04 May 2010 ~ Comments Off on Reducing health disparities: from theory to practice

Reducing health disparities: from theory to practice

Continue Reading

04 May 2010 ~ Comments Off on Strategies for community participation in cancer prevention

Strategies for community participation in cancer prevention

Continue Reading

04 May 2010 ~ Comments Off on The Georgia Cancer Coalition

The Georgia Cancer Coalition

Continue Reading

04 May 2010 ~ Comments Off on Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities

Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities

Advancements in pharmacogenomics and chemoprevention promise to reduce cancer incidence and mortality, but utilization will undoubtedly be accompanied with ethical and legal issues that largely remain unexplored or discussed. As pharmacogenomic information is assessed more comprehensively and inexpensively, it will influence decisions regarding when and to whom chemoprevention therapy will be initiated. Pharmacogenomics will change […]

Continue Reading